StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.04−0.04 (-3.70%)

Close on Nov 18, 2026Market cap $6.81MP/E –Yield –

Exicure operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Exicure's operating cash flow for the twelve months ending Jun 30, 2026 was -$6.70M. For fiscal 2025 it was -$8.56M. The highest annual figure on record is $1.32M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.56M–
FY2024Dec 31, 2024-$2.91M–
FY2023Dec 31, 2023-$10.36M–
FY2022Dec 31, 2022-$35.66M–
FY2021Dec 31, 2021-$34.82M–
FY2020Dec 31, 2020-$39.27M-3081.8%
FY2019Dec 31, 2019$1.32M–
FY2018Dec 31, 2018-$19.49M–
FY2017Dec 31, 2017-$19.79M–
FY2016Dec 31, 2016-$5.05M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$887.00K–
Q1 FY2026Mar 31, 2026-$1.14M–
Q4 FY2025Dec 31, 2025-$1.15M–
Q3 FY2025Sep 30, 2025-$3.53M–
Q2 FY2025Jun 30, 2025-$2.28M–
Q1 FY2025Mar 31, 2025-$1.60M–
Q4 FY2024Dec 31, 2024-$845.00K–
Q3 FY2024Sep 30, 2024-$449.00K–
Q2 FY2024Jun 30, 2024-$1.17M–
Q1 FY2024Mar 31, 2024-$450.00K–
Q4 FY2023Dec 31, 2023-$816.00K–
Q3 FY2023Sep 30, 2023-$1.41M–
Q2 FY2023Jun 30, 2023-$4.81M–
Q1 FY2023Mar 31, 2023-$3.32M–
Q4 FY2022Dec 31, 2022-$7.28M–
Q3 FY2022Sep 30, 2022-$6.55M-234.6%
Q2 FY2022Jun 30, 2022-$9.08M–
Q1 FY2022Mar 31, 2022-$12.76M–
Q4 FY2021Dec 31, 2021-$13.80M–
Q3 FY2021Sep 30, 2021$4.86M–
Q2 FY2021Jun 30, 2021-$11.08M–
Q1 FY2021Mar 31, 2021-$14.81M–
Q4 FY2020Dec 31, 2020-$11.81M-177.0%
Q3 FY2020Sep 30, 2020-$8.65M–
Q2 FY2020Jun 30, 2020-$10.97M–
Q1 FY2020Mar 31, 2020-$7.85M–
Q4 FY2019Dec 31, 2019$15.33M–
Q3 FY2019Sep 30, 2019-$5.02M–
Q2 FY2019Jun 30, 2019-$4.98M–
Q1 FY2019Mar 31, 2019-$4.01M–
Q4 FY2018Dec 31, 2018-$5.96M–
Q3 FY2018Sep 30, 2018-$4.19M-174.5%
Q2 FY2018Jun 30, 2018-$4.68M–
Q1 FY2018Mar 31, 2018-$4.65M–
Q4 FY2017Dec 31, 2017-$5.34M–
Q4 FY2016Dec 31, 2016$5.63M–

More Exicure figures

See a number that looks wrong?